James Healy
James Healy has made 1 open-market purchase worth $20.4M since Oct 30, 2026, in 1 company. The latest: $20.4M of RAPP, filed Oct 30, 2026, scored 72 out of 100.
Director, Rapport Therapeutics, Inc.
Follow James Healy, freeOpen the live feed
A free account gets an alert the minute a new buy or sale is filed.
Purchases
| Filed | Stock | Stake | Score | Bought | 1 week | 1 month |
|---|---|---|---|---|---|---|
| Oct 30 Form 4 (opens sec.gov) |
RAPPRapport Therapeutics, Inc. · DirectorDirector · 7 insiders buying · Near 52-week low | +51% stake | 72 | $20.4M 969,480 at $21.00 |
waiting | waiting |
Questions
What stock has James Healy bought?
RAPP (Rapport Therapeutics, Inc.), all on the open market and reported on SEC Form 4.
When did James Healy last buy?
Oct 30, 2026: 969,480 shares of RAPP at $21.00, $20.4M in all (Form 4 (opens sec.gov)).
Has James Healy filed a notice of a planned sale?
Not in the filings on record. A Form 144 is the notice an insider must file before selling restricted or control shares, and it lands on EDGAR before the sale is reported.
Is James Healy a routine or an opportunistic buyer?
There isn't enough history to say yet.
Data as of Oct 30, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer